4426-72-6Relevant articles and documents
-
Baker,Gilbert
, p. 2777 (1942)
-
Chelates with π-stacking and hydrogen-bonding interactions as safer and structurally reinforced energetic materials
Yang, Li,Li, Hongrun,Zhang, Guoying,Liu, Jianchao,Tong, Wenchao
, p. 405 - 409 (2017)
Three chelating energetic materials (CEM), [Co(SCZ)2(H2O)2](TNR)(H2O)2 (1), [Ni(SCZ)2(H2O)2](TNR)(H2O)2 (2) and [Zn(SCZ)2(H2/sub
-
Holroyd
, p. 1326 (1901)
-
Synthesis and biological screening of novel thiadiazoles, selenadiazoles, and spirocyclic benzopyran by ultrasonic and microwave irradiation
Shinde,Sonar,Shingate,Shingare
, p. 1594 - 1603 (2010)
We describe the synthesis of novel thiadiazole, selenadiazole, and spirocyclic benzopyrans via the semicarbazides 3 and thiosemicarbazides 3 of 2-ethyl-2-methyl-4H-chromen-4-ones 1 by conventional and nonconventional methods. The microwave and ultrasonic irradiation methods form the respective products in excellent yields in very short reaction time as compared to the conventional method. The synthesized compounds were tested for antimicrobial screening against bacteria and fungi show moderate activity. Supplemental materials are available for this article. Go to the publisher's online edition of Phosphorus, Sulfur, and Silicon and the Related Elements to view the free supplemental file. Copyright Taylor & Francis Group, LLC.
-
Briner,Hoefer
, p. 913 (1943)
-
Insight on a new indolinone derivative as an orally bioavailable lead compound against renal cell carcinoma
Fouad, Marwa A.,Zaki, Mayssoune Y.,Lotfy, Raghda A.,Mahmoud, Walaa R.
, (2021/06/15)
A series of novel 3-indolinone-thiazolidinones and oxazolidinones 4a-k was synthesized via molecular hybridization approach and sequentially evaluated to explore its cytotoxic activity. The cytotoxicity screening pointed toward the N-cyclohexyl thiazolidinone derivative 4f that revealed promising renal cytotoxicity against CAKI-1 and UO-31 renal cancer cell lines with IC50 values 4.74 and 3.99 μM, respectively, which were comparable to those of sunitinib along with good safety threshold against normal renal cells. Further emphasis on compound 4f renal cytotoxicity was achieved via different enzyme assays and CAKI-1 and UO-31 cell cycle analysis. The results were supported by in silico studies to explore its physicochemical, pharmacokinetic and drug-likeness properties. Finally, compound 4f was subjected to an in vivo pharmacokinetic study through two different routes of administration showing excellent oral bioavailability. This research represents compound 4f as a promising candidate against renal cell carcinoma.
Peptidomimetics comprising N-amino cyclic urea residues and uses thereof
-
Page/Page column, (2015/04/15)
Novel peptidomimetics comprising N-amino cyclic urea residues are disclosed. Use of such peptidomimetics for modulating the activity of CD36 or IL-1 receptor in a cell, and for treating CD36- or IL-1-related disease, disorder or condition is also described.
